Abstract:Background Gene therapy applications require safe and efficient methods for gene transfer. Present methods are restricted by low efficiency and short duration of transgene expression. In vivo electroporation, a physical method of gene transfer, has evolved as an efficient method in recent years. We present a protocol involving electroporation combined with a long-acting promoter system for gene transfer to the lung.Methods The study was designed to evaluate electroporation-mediated gene transfer to the lung and to analyze a promoter system that allows prolonged transgene expression. A volume of 250 mu l of purified plasmid DNA suspended in water was instilled into the left lung of anesthetized rats, followed by left thoracotomy and electroporation of the exposed left lung. Plasmids pCiKlux and pUblux expressing luciferase under the control of the cytomegalovirus immediate-early promoter/enhancer (CMV-IEPE) or human polyubiquitin c (Ubc) promoter were used. Electroporation conditions were optimized with four pulses (200 V/cm, 20 ms at 1 Hz) using flat plate electrodes. The animals were sacrificed at different time points up to day 40, after gene transfer. Gene expression was detected and quantified by bioluminescent reporter imaging (BLI) and relative light units per milligram of protein (RLU/mg) was measured by luminometer for p.Pyralis luciferase and immunohistochemistry, using an anti-luciferase antibody.Results Gene expression with the CMV-IEPE promoter was highest 24 h after gene transfer (2932 +/- 249.4 relative light units (RLU)/mg of total lung protein) and returned to baseline by day 3 (382 +/- 318 RLU/mg of total lung protein); at day 5 no-expression was detected, whereas gene expression under the Ubc promoter was detected up to day 40 (1989 +/- 710 RLU/mg of total lung protein) with a peak at day 20 (2821 +/- 2092 RLU/mg of total lung protein). Arterial blood gas (PaO2), histological assessment and cytokine measurements showed no significant toxicity neither at day 1 nor at day 40.Conclusions These results provide evidence that in vivo electroporation is a safe and effective tool for non-viral gene delivery to the lungs. If this method is used in combination with a long-acting promoter system, sustained transgene expression can be achieved. Copyright (c) 2006 John Wiley & Sons, Ltd.

CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression

Enabling non-viral DNA delivery using lipid nanoparticles co-loaded with endogenous anti-inflammatory lipids

A Two‐Pronged Pulmonary Gene Delivery Strategy: A Surface‐Modified Fullerene Nanoparticle and a Hypotonic Vehicle

Encapsulating Polyethyleneimine-DNA Nanoplexes into PEGylated Biodegradable Microparticles Increases Transgene Expression In Vitro and Reduces Inflammatory Responses In Vivo

Electroporation Enhances Reporter Gene Expression Following Delivery of Naked Plasmid Dna to the Lung

Prolonged Gene Expression in Mouse Lung Endothelial Cells Following Transfection with Epstein–Barr Virus-Based Episomal Plasmid

Eliminating bacteria backbone of naked DNA enhanced hFIX expression and reduced inflammatory response in mice.

Plasmid DNA Cationic Non-Viral Vector Complexes Induce Cytotoxicity-Associated PD-L1 Expression Up-Regulation in Cancer Cells in Vitro.

Enhanced Immunostimulatory Activity of a Cytosine-Phosphate-Guanosine Immunomodulator by the Assembly of Polymer DNA Wires and Spheres

PEGylated enhanced cell penetrating peptide nanoparticles for lung gene therapy

Highly Branched Poly Β-Amino Ester/cpg-Depleted CFTR Plasmid Nanoparticles for Non-viral Gene Therapy in Lung Cystic Fibrosis Disease

In Vivo Electroporation and Ubiquitin Promoter - A Protocol for Sustained Gene Expression in the Lung

Marked enhancement of direct respiratory tissue transfection by aurintricarboxylic acid

Repeated Intrathecal Administration of Plasmid DNA Complexed with Polyethylene Glycol-Grafted Polyethylenimine Led to Prolonged Transgene Expression in the Spinal Cord

Effective pulmonary delivery of an aerosolized plasmid DNA vaccine via surface acoustic wave nebulization

Inhaled gene therapy of preclinical muco-obstructive lung diseases by nanoparticles capable of breaching the airway mucus barrier

Efficiency of Non-Viral Gene Delivery Systems to Rat Lungs.

Cpg Dna-Mediated Immune Response In Pulmonary Endothelial Cells

Non-Methylated Cpg Motif Packaged into Fusogenic Liposomes Enhance Antigen-Specific Immunity in Mice

Effects of Linear Polyethylenimine and Polyethylenimine/DNA on Lung Function after Airway Instillation to Rat Lungs